RESUMO
BACKGROUND: The relationship and behavior of serum immunoglobulin E (IgE) level, peripheral blood mononuclear cell (PBMC) human leukocyte antigen DR (HLA-DR) expression and erythrocyte glutathione antioxidant pathway in asthma patients treated with systemic ozone therapy have not been studied before. METHODS: Asthma patients were treated about 1 year with three cycles (5 or 6 months each) with three different ozone therapy protocols. Ozone major autohemotherapy (MAHT) was applied at doses of 4 and 8 mg, 15 sessions each cycle; and ozone rectal insufflations (RI) at a dose of 10 mg, 20 sessions each cycle. Serum IgE, HLA-DR expression in PBMC and biomarkers for antioxidant pathway were measured before and at the end of each cycle. Lung function and symptoms test were recorded at the beginning and after the third cycle. RESULTS: IgE and HLA-DR decreased with the three types of treatments, while increments in reduced glutathione, glutathione peroxidase, glutation reductase and glutathione S-transferase were achieved with all treatments. Lung function and symptoms test were markedly improved. However, in all parameters the best response was obtained in the order: MAHT at 8 mg better than MAHT at 4 mg better than RI at 10 mg. Before ozone treatment, glutathione antioxidant parameters were under the normal reference values, suggesting the occurrence of oxidative stress associated with atopic asthma. CONCLUSIONS: This study demonstrates the effectiveness of ozone therapy in reducing IgE and inflammatory mediators along with the induction of antioxidant elements. The study raises the role of systemic ozone therapy in atopic asthma by means of its immunomodulatory and oxidative stress regulation properties.
Assuntos
Asma/terapia , Biomarcadores , Pulmão/fisiologia , Oxidantes Fotoquímicos/uso terapêutico , Ozônio/uso terapêutico , Adolescente , Adulto , Antioxidantes/metabolismo , Asma/imunologia , Hiper-Reatividade Brônquica , Feminino , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Glutationa Transferase/metabolismo , Antígenos HLA-DR/sangue , Antígenos HLA-DR/imunologia , Humanos , Imunoglobulina E/sangue , Imunoglobulina E/imunologia , Masculino , Pessoa de Meia-IdadeRESUMO
Uno de los cuadros clínicos de instalación más impresionante que obligan al especialista en Otorrinolaringología a actuar bajo criterios de protocolo clínico y de tratamiento, es la aparición de una hipoacusia neurosensorial de instalación rápidamente progresiva. Causas vasculares, virales e inmunológicas, por sí solas o de manera interactiva, han sido señaladas como responsables de los trastornos que se originan, los cuales confluyen en la pérdida de la audición. Por todas estas razones, nos dimos a la tarea de evaluar los resultados obtenidos tras aplicar la combinación de dos métodos de tratamiento, los cuales, de acuerdo con la información de que se dispone, pueden ser efectivos en la atención de esta patología. Resultado significativo del protocolo de tratamiento fue una tasa de recuperación del 88 por ciento de los pacientes tratados(AU)
One of the most impressive installation clinical pictures that obliges the Otorhinolaryngology specialist to act under the criteria of clinical protocol and treatment is the appearance of a rapidly progressive installation neurosensorial hypoacusia. Vascular, viral and immunological causes by themselves, or in an interactive manner, have been considered responsible for the disorders that are originated and that lead to a clinical picture of auditive loss. For all these reasons, we decided to evaluate the results obtained after applying the combination of two treatment methods, which, according to the available information, may be effective in the attention of this pathology. A significant result of the treatment protocol was the recovery rate of 88 percent of the treated patients(AU)